The US OTC drug market is anticipated to grow at a CAGR of 5.8% during the forecast period (2019-2025). The pharma players are increasingly shifting towards the OTC landscape owing to the growing preference of consumers and are bringing new drugs at an affordable price in the market. For the pharma companies in the US, OTC drugs are a huge business accounting for billions of dollars in revenue. Despite the lower per-unit costs, OTC drugs often surpass prescription drugs in terms of annual sales.
Browse the full report description US OTC Drugs Market Size, Share & Trends Analysis Report By Product Type (Analgesics & Pain Relievers; Cough, Cold & Flu Products; Vitamin & Mineral Supplements; Ophthalmic Products; and Others), By Distribution Channel (Retail & Supermarkets and Online Platform), and Forecast 2019-2025 at https://www.omrglobal.com/industry-reports/us-over-the-counter-otc-drugs-market
Some of the Top-Selling OTC Drugs in 2018
Ranking |
Drug Category |
Revenue ($ Million) |
1 |
Upper respiratory remedies |
8,799 |
2 |
Oral Analgesics |
4,323 |
3 |
Heartburn |
3,229 |
4 |
Antiperspirants |
3,034 |
5 |
Toothpaste |
2,866 |
6 |
Oral antiseptics and rinses |
1,461 |
7 |
Laxative |
1,381 |
8 |
First Aid |
1,269 |
9 |
Lip/oral treatment |
1,189 |
10 |
Sun protection |
1,183 |
11 |
Eye Care |
1,165 |
Key Questions Addressed by the Report
US OTC Drugs Market Report Segment
By Product Type
By Distribution Channel
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/us-over-the-counter-otc-drugs-market